EDP-420 / Duration of Treatment - 3 days
EDP420-05-006
Phase 2 small_molecule active
Quick answer
EDP-420 / Duration of Treatment - 3 days for Community Acquired Pneumonia is a Phase 2 program (small_molecule) at ENANTA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ENANTA PHARMACEUTICALS INC
- Indication
- Community Acquired Pneumonia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active